When the pandemic first hit, there was no playbook. At Mapmygenome, we realized early on that waiting for a cure wasn't enough—we needed to focus on prevention and immunity. We went back to our core mission: using the power of genomics to help people understand their health risks and take control of their well-being.
Through hard work, automated workflows, and pioneering research, our team adapted swiftly to the challenges of COVID-19. Here is a look behind the scenes at how we pivoted to fight the virus.
Redefining Immunity with the Genomepatri Immunity Report
With no specific drugs available for COVID-19 initially, the medical community relied heavily on experimental treatments. We realized we could help. By leveraging our database, we began analyzing genetic warning signs to understand how individuals might react to specific antiviral drugs.
This research led to the launch of our Genomepatri Immunity Report. This specialized report helps individuals understand their:
-
Genetic risk for the virus
-
Potential infection severity
-
Risk for associated comorbidities
-
Nutrient deficiencies that could negatively impact overall immunity
